Estimation of the Acute Myocardial Infarction Onset Time based on Time-Course Acquisitions.

Acute myocardial infarction Biological models Cardiac biomarkers Identifiability Infarct time System identification

Journal

Annals of biomedical engineering
ISSN: 1573-9686
Titre abrégé: Ann Biomed Eng
Pays: United States
ID NLM: 0361512

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 18 02 2020
accepted: 10 07 2020
pubmed: 30 7 2020
medline: 22 9 2021
entrez: 30 7 2020
Statut: ppublish

Résumé

Quantitative analysis of biochemical parameters is crucial for a correct diagnosis and prognosis of patients subject to acute myocardial infarction (AMI). In order to achieve a quantitative understanding of the dynamics of cardiac biomarkers, we have developed a mathematical model that can be exploited to extrapolate the release curve of cardiac troponin T (cTnT) into the plasma from few experimental acquisitions. The present work introduces a novel approach, based on the cTnT-release model, aimed at the identification of the infarct onset time. Indeed, in spite of the clinical importance of such information, in many cases, it is not easy to establish the exact time of occurrence of the ischemic event. We show that using a model-based optimization approach, the infarct onset time can be reliably estimated using the cTnT concentration acquisitions taken in the first few hours post-AMI. The assessment of the proposed approach is conducted on an experimental dataset, in which the infarct has been artificially induced and, therefore, the onset time is exactly known. In particular, the effectiveness of the devised estimation algorithm has been tested under several scenarios, with the first cTnT acquisition taken up to 12 h after AMI. Altogether, the proposed model-based approach provides a useful tool to help the clinicians in the quantitative estimation of important clinical parameters from the release curves of the cardiac biomarkers.

Identifiants

pubmed: 32725546
doi: 10.1007/s10439-020-02568-z
pii: 10.1007/s10439-020-02568-z
doi:

Substances chimiques

Biomarkers 0
Troponin T 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

477-486

Subventions

Organisme : Regione Calabria
ID : POR Calabria FESR/FSE 2014/20

Références

Chapman, M. J., K. R. Godfrey, M. J. Chappell, and N. D. Evans. Structural identifiability for a class of non-linear compartmental systems using linear/non-linear splitting and symbolic computation. Math. Biosci. 183:1–14, 2003.
doi: 10.1016/S0025-5564(02)00223-7
Chis, O., J. R. Banga, and E. Balsa-Canto. Structural identifiability of systems biology models: a critical comparison of methods. PLoS ONE 6:e27755, 2011.
doi: 10.1371/journal.pone.0027755
Crank, J. The Mathematics of Diffusion. London: Oxford University Press, 1979.
Ibanez, B., et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the Management of Acute Myocardial Infarction in patients Presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 39:119–177, 2018.
doi: 10.1093/eurheartj/ehx393
Liebetrau, C., L. Gaede, J. S. Wolter, J. Homann, A. Meyer, O. Dörr, H. M. Nef, C. Troidl, C. W. Hamm, H. Möllmann, et al. Release kinetics of high-sensitivity cardiac troponins I and T and troponin T upstream open reading frame peptide (TnTuORF) in clinically induced acute myocardial infarction. Biomarkers 22:304–310, 2017.
doi: 10.1080/1354750X.2016.1252965
McManus, D. D., J. Gore, J. Yarzebski, F. Spencer, D. Lessard, and R. J. Goldberg. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am. J. Med. 124:40–47, 2011.
doi: 10.1016/j.amjmed.2010.07.023
Miao, H., X. Xia, A. S. Perelson, and H. Wu. On identifiability of nonlinear ODEmodels and applications in viral dynamics. SIAM Rev. 53:3–39, 2011.
doi: 10.1137/090757009
Procopio, A., S. De Rosa, M. R. García, C. Covello, A. Merola, J. Sabatino, A. De Luca, C. Indolfi, F. Amato, and C. Cosentino. Experimental modeling and identification of cardiac biomarkers release in acute myocardial infarction. IEEE Trans. Control Syst. Technol. 28(1):1–13, 2018.
Rodriguez, F. and K. W. Mahaffey. Updates to the ACCF/AHA and ESC STEMI and NSTEMI guidelines: putting guidelines into clinical practice. J. Am. Coll. Cardiol. 68:313–321, 2016.
doi: 10.1016/j.jacc.2016.03.599
Roffi, M., et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 37:267–315, 2016.
doi: 10.1093/eurheartj/ehv320
Thygesen, K., J. S. Alpert, A. S. Jaffe, B. R. Chaitman, J. J. Bax, D. A. Morrow, H. D. White, et al. Fourth universal definition of myocardial infarction (2018). J. Am. Coll. Cardiol. 72:2231–2264, 2018.
doi: 10.1016/j.jacc.2018.08.1038
Villaverde, A. F., A. Barreiro, and A. Papachristodoulou. Structural identifiability of dynamic systems biology models. PLoS Comput. Biol. 12:e1005153, 2016.
doi: 10.1371/journal.pcbi.1005153
Waltz, R., J. Morales, J. Nocedal, and D. Orban. An interior algorithm for nonlinear optimization that combines line search and trust region steps. Math. Program. 107:391–408, 2006.
doi: 10.1007/s10107-004-0560-5

Auteurs

Anna Procopio (A)

Biomechatronics Lab, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi Magna Græcia, Catanzaro, Italy.

Salvatore De Rosa (S)

Interventional Cardiology Unit, Department of Medical and Surgical Sciences, Università degli Studi Magna Græcia, Catanzaro, Italy.
Interventional Cardiology Unit, Department of Experimental and Clinical Medicine, Università degli Studi Magna Græcia, Catanzaro, Italy.

Caterina Covello (C)

Interventional Cardiology Unit, Department of Medical and Surgical Sciences, Università degli Studi Magna Græcia, Catanzaro, Italy.
Interventional Cardiology Unit, Department of Experimental and Clinical Medicine, Università degli Studi Magna Græcia, Catanzaro, Italy.

Alessio Merola (A)

Biomechatronics Lab, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi Magna Græcia, Catanzaro, Italy.

Jolanda Sabatino (J)

Interventional Cardiology Unit, Department of Medical and Surgical Sciences, Università degli Studi Magna Græcia, Catanzaro, Italy.
Interventional Cardiology Unit, Department of Experimental and Clinical Medicine, Università degli Studi Magna Græcia, Catanzaro, Italy.

Alessia De Luca (A)

Interventional Cardiology Unit, Department of Medical and Surgical Sciences, Università degli Studi Magna Græcia, Catanzaro, Italy.
Interventional Cardiology Unit, Department of Experimental and Clinical Medicine, Università degli Studi Magna Græcia, Catanzaro, Italy.

Christoph Liebetrau (C)

Kerckhoff Heart and Thorax Center, Department of Cardiology, Bad Nauheim, German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Frankfurt, Germany.
Medical Clinic I, Division of Cardiology, Justus Liebig University Giessen, Giessen, Germany.

Christian W Hamm (CW)

Kerckhoff Heart and Thorax Center, Department of Cardiology, Bad Nauheim, German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Frankfurt, Germany.
Medical Clinic I, Division of Cardiology, Justus Liebig University Giessen, Giessen, Germany.

Ciro Indolfi (C)

Interventional Cardiology Unit, Department of Experimental and Clinical Medicine, Università degli Studi Magna Græcia, Catanzaro, Italy.

Francesco Amato (F)

Dipartimento di Ingegneria Elettrica e delle Tecnologie dell'Informazione, Università degli Studi di Napoli Federico II, Napoli, Italy.

Carlo Cosentino (C)

Biomechatronics Lab, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi Magna Græcia, Catanzaro, Italy. carlo.cosentino@unicz.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH